To exclude the possible effect of proliferation inhibition on irinotecan sensitivity, we selected a colorectal cancer cell line, SW620, which showed least sensitive to eIF3a‐knockdown‐induced proliferation inhibition. The gene discussed is EIF3A; the disease is colorectal cancer.